{"lastClose": 12.770000457763672, "len": 1203, "date": "2023-03-07", "alpha_1": 0.7422639990370425, "beta_1": 0.8685675552197334, "drawup_1": 1.2434209803960319, "sharpe_1": 0.7772254012480955, "natr_1": 5.2898097726812585, "sup_1": -0.11028452701688801, "res_1": 0.11811533549071329, "bullPattern_1": [], "bearPattern_1": ["THRUSTING"], "rsi_1": 41.16022139473838, "adx_1": 11.9407585537534, "drawdown_1": -0.33391761557680333, "stratHoldSharpe_1": 0.7325201397012131, "stratHoldAlpha_1": 251.39714771943844, "stratHoldDrawdown_1": -0.30512546745041536, "alpha_3mo": -0.6010906550067181, "beta_3mo": 0.5755033042729655, "drawup_3mo": 0.09349033384347871, "natr_3mo": 5.2898097726812585, "sup_3mo": -0.017175746014258954, "res_3mo": 0.07206989489020767, "bullPattern_3mo": ["SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 41.79775935865092, "adx_3mo": 11.821994114639665, "drawdown_3mo": -0.22621299171240783, "stratHoldSharpe_3mo": -1.573188223803803, "stratHoldAlpha_3mo": 250.39995825962825, "stratHoldDrawdown_3mo": -0.20440312286078255, "Country": "United States", "Industry": "Biotechnology: Pharmaceutical Preparations", "Name": "Kiniksa Pharmaceuticals Ltd. Class A", "Market Cap": 891049530, "Sector": "Health Care", "IPO Year": 2018.0, "alpha%_1": 0.9948308264588078, "beta%_1": 0.41885546791412664, "drawup%_1": 0.9722647029192646, "sharpe%_1": 0.5327983282368831, "natr%_1": 0.7233325809598322, "drawdown%_1": 0.5900576393267691, "stratHoldSharpe%_1": 0.7642632258559151, "stratHoldAlpha%_1": 0.8896266802323689, "stratHoldDrawdown%_1": 0.590802911424903, "alpha%_3mo": 0.1062133342743965, "beta%_3mo": 0.25720378166953295, "drawup%_3mo": 0.17837366397936683, "natr%_3mo": 0.7167461518535068, "drawdown%_3mo": 0.15686134338901003, "stratHoldSharpe%_3mo": 0.10283657194371487, "stratHoldAlpha%_3mo": 0.08062311518102366, "stratHoldDrawdown%_3mo": 0.16378443825954514}